BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 25534278)

  • 1. Proposal of a post-prostatectomy clinical target volume based on pre-operative MRI: volumetric and dosimetric comparison to the RTOG guidelines.
    Croke J; Maclean J; Nyiri B; Li Y; Malone K; Avruch L; Kayser C; Malone S
    Radiat Oncol; 2014 Dec; 9():303. PubMed ID: 25534278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.
    Malone S; Croke J; Roustan-Delatour N; Belanger E; Avruch L; Malone C; Morash C; Kayser C; Underhill K; Li Y; Malone K; Nyiri B; Spaans J
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):725-32. PubMed ID: 22444999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anatomic variations due to radical prostatectomy. Impact on target volume definition and dose-volume parameters of rectum and bladder.
    Sanguineti G; Castellone P; Foppiano F; Franzone P; Marcenaro M; Tognoni P; Bolognesi A; Ceresoli GL; Fiorino C
    Strahlenther Onkol; 2004 Sep; 180(9):563-72. PubMed ID: 15378187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in target volumes definition by using MRI for prostate bed radiotherapy planning--preliminary results].
    Sefrová J; Paluska ; Odrázka K; Belobradek Z; Hoffmann P; Prosvic P; Brod'ák M; Louda M; Macingová Z; Vosmik M
    Klin Onkol; 2010; 23(4):256-63. PubMed ID: 20806824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local recurrence map to guide target volume delineation after radical prostatectomy.
    Wang J; Kudchadker R; Choi S; Pettaway CA; Choi H; Hobbs BD; Occena MC; McGuire SE; Pugh TJ; Hoffman K; Mahmood U; Kuban DA
    Pract Radiat Oncol; 2014; 4(6):e239-46. PubMed ID: 25407875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative radiotherapy in prostate cancer: the case of the missing target.
    Croke J; Malone S; Roustan Delatour N; Belanger E; Avruch L; Morash C; Kayser C; Underhill K; Spaans J
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1160-8. PubMed ID: 22270169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy.
    Stanic S; Mathai M; Cui J; Purdy JA; Valicenti RK
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1897-902. PubMed ID: 21536391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of adaptive planning in margin-reduced, MRI-guided stereotactic body radiotherapy to the prostate bed following radical prostatectomy: Post-hoc analysis of a phase II clinical trial.
    Nikitas J; Smith LM; Gao Y; Ma TM; Sachdeva A; Yoon SM; Jiang T; Low DA; Ballas LK; Steinberg ML; Cao M; Kishan AU
    Radiother Oncol; 2023 Jun; 183():109631. PubMed ID: 36934894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of anatomical interventions on the localization of post-prostatectomy cancer patients.
    Diot Q; Olsen C; Kavanagh B; Raben D; Miften M
    Med Phys; 2010 Feb; 37(2):629-37. PubMed ID: 20229872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy.
    Mock U; Bogner J; Georg D; Auberger T; Pötter R
    Strahlenther Onkol; 2005 Jul; 181(7):448-55. PubMed ID: 15995838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy.
    Myrehaug S; Chan G; Craig T; Weinberg V; Cheng C; Roach M; Cheung P; Sahgal A
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e657-62. PubMed ID: 22245189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging in postprostatectomy radiotherapy planning.
    Sefrova J; Odrazka K; Paluska P; Belobradek Z; Brodak M; Dolezel M; Prosvic P; Macingova Z; Vosmik M; Hoffmann P; Louda M; Nejedla A
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):911-8. PubMed ID: 21420244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective MRI-based imaging study to assess feasibility of proton therapy for post-prostatectomy radiation.
    Swisher-McClure S; Yin L; Rosen M; Batra S; Berman AT; Both S; Vapiwala N
    Acta Oncol; 2016 Jul; 55(7):828-33. PubMed ID: 27145164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postprostatectomy target-normal structure overlap volume differences using computed tomography and radioimmunoscintigraphy images for radiotherapy treatment planning.
    Su A; Blend MJ; Spelbring D; Hamilton RJ; Jani AB
    Clin Nucl Med; 2006 Mar; 31(3):139-44. PubMed ID: 16495731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric and radiobiologic comparison of 3D conformal versus intensity modulated planning techniques for prostate bed radiotherapy.
    Koontz BF; Das S; Temple K; Bynum S; Catalano S; Koontz JI; Montana GS; Oleson JR
    Med Dosim; 2009; 34(3):256-60. PubMed ID: 19647638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coverage optimized planning: probabilistic treatment planning based on dose coverage histogram criteria.
    Gordon JJ; Sayah N; Weiss E; Siebers JV
    Med Phys; 2010 Feb; 37(2):550-63. PubMed ID: 20229863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Volumetric and dosimetric comparison of organs at risk between the prone and supine positions in postoperative radiotherapy for prostate cancer.
    Sawayanagi S; Yamashita H; Ogita M; Kiritoshi T; Nakamoto T; Abe O; Nakagawa K
    Radiat Oncol; 2018 Apr; 13(1):70. PubMed ID: 29665832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus Guidelines and Contouring Atlas for Pelvic Node Delineation in Prostate and Pelvic Node Intensity Modulated Radiation Therapy.
    Harris VA; Staffurth J; Naismith O; Esmail A; Gulliford S; Khoo V; Lewis R; Littler J; McNair H; Sadoyze A; Scrase C; Sohaib A; Syndikus I; Zarkar A; Hall E; Dearnaley D;
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):874-83. PubMed ID: 26104940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the dosimetric impact of non-exclusion of the rectum from the boost PTV in IMRT treatment plans for prostate cancer patients.
    Kassim I; Dirkx ML; Heijmen BJ
    Radiother Oncol; 2009 Jul; 92(1):62-7. PubMed ID: 19278745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative radiotherapy for prostate cancer : evaluation of target motion and treatment techniques (intensity-modulated versus conformal radiotherapy).
    Pinkawa M; Siluschek J; Gagel B; Piroth MD; Demirel C; Asadpour B; Eble MJ
    Strahlenther Onkol; 2007 Jan; 183(1):23-9. PubMed ID: 17225942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.